Andrew M. Creighton

793 total citations
15 papers, 683 citations indexed

About

Andrew M. Creighton is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Andrew M. Creighton has authored 15 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Toxicology. Recurrent topics in Andrew M. Creighton's work include Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Neutropenia and Cancer Infections (2 papers). Andrew M. Creighton is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Neutropenia and Cancer Infections (2 papers). Andrew M. Creighton collaborates with scholars based in United Kingdom, United States and Canada. Andrew M. Creighton's co-authors include C. Stephen Downes, Duncan J. Clarke, Robert T. Johnson, Ann M. Mullinger, Juan F. Giménez-Abián, Jack C. Yalowich, Brian B. Hasinoff, Theodore I. Kuschak, David R. Williams and Peter M. May and has published in prestigious journals such as Nature, Nature Biotechnology and Journal of Cell Science.

In The Last Decade

Andrew M. Creighton

15 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew M. Creighton United Kingdom 12 507 230 107 100 99 15 683
M K Ritke United States 9 410 0.8× 221 1.0× 42 0.4× 78 0.8× 40 0.4× 9 632
Gene K. Yee United States 8 383 0.8× 171 0.7× 97 0.9× 76 0.8× 69 0.7× 12 706
Sandra A. Murphree United States 12 395 0.8× 150 0.7× 115 1.1× 49 0.5× 42 0.4× 15 621
Elisabetta Corna Italy 16 454 0.9× 339 1.5× 25 0.2× 47 0.5× 52 0.5× 35 726
Aurelio Di Marco Italy 17 468 0.9× 407 1.8× 207 1.9× 207 2.1× 12 0.1× 33 924
Y.-H. Ling United States 13 333 0.7× 226 1.0× 25 0.2× 46 0.5× 28 0.3× 24 582
S Kirschenbaum United States 7 576 1.1× 342 1.5× 57 0.5× 104 1.0× 10 0.1× 9 728
Abdul M. Deffie Canada 9 539 1.1× 491 2.1× 22 0.2× 57 0.6× 30 0.3× 10 726
Jean‐Claude Jardillier France 16 373 0.7× 213 0.9× 11 0.1× 100 1.0× 43 0.4× 29 670
Sartorelli Ac United States 13 393 0.8× 157 0.7× 19 0.2× 90 0.9× 21 0.2× 28 614

Countries citing papers authored by Andrew M. Creighton

Since Specialization
Citations

This map shows the geographic impact of Andrew M. Creighton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Creighton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Creighton more than expected).

Fields of papers citing papers by Andrew M. Creighton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Creighton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Creighton. The network helps show where Andrew M. Creighton may publish in the future.

Co-authorship network of co-authors of Andrew M. Creighton

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Creighton. A scholar is included among the top collaborators of Andrew M. Creighton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Creighton. Andrew M. Creighton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kaufmann, William K., Dennis A. Simpson, Paula B. Deming, et al.. (2002). Degradation of ATM-Independent Decatenation Checkpoint Function in Human Cells is Secondary to Inactivation of p53 and Correlated with Chromosomal Destabilization. Cell Cycle. 1(3). 209–218. 16 indexed citations
2.
Patel, Sandhiya, Elen Jazrawi, Andrew M. Creighton, Caroline A. Austin, & L. Mark Fisher. (2000). Probing the Interaction of the Cytotoxic Bisdioxopiperazine ICRF-193 with the Closed Enzyme Clamp of Human Topoisomerase IIα. Molecular Pharmacology. 58(3). 560–568. 22 indexed citations
3.
Patel, Sandhiya, Elen Jazrawi, Andrew M. Creighton, Caroline A. Austin, & L. Mark Fisher. (2000). Probing the Interaction of the Cytotoxic Bisdioxopiperazine ICRF-193 with the Closed Enzyme Clamp of Human Topoisomerase IIα. Molecular Pharmacology. 58(3). 560–568. 2 indexed citations
4.
Hasinoff, Brian B., Theodore I. Kuschak, Andrew M. Creighton, et al.. (1997). Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II. Biochemical Pharmacology. 53(12). 1843–1853. 40 indexed citations
5.
Hasinoff, Brian B., et al.. (1997). Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site. Molecular Pharmacology. 52(5). 839–845. 48 indexed citations
6.
Pérez, Concepción, Nuria Vilaboa, Laura García‐Bermejo, et al.. (1997). Differentiation of U-937 promonocytic cells by etoposide and ICRF-193, two antitumour DNA topoisomerase II inhibitors with different mechanisms of action. Journal of Cell Science. 110(3). 337–343. 30 indexed citations
7.
Neri, Dario, Greg Winter, Yvonne Light, et al.. (1996). Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [γ-32P]-ATP. Nature Biotechnology. 14(4). 485–490. 42 indexed citations
8.
Creighton, Andrew M., Dario Neri, Pier Giorgio Natali, et al.. (1996). Recombinant Anti-Human Melanoma Antibodies Are Versatile Molecules. Journal of Investigative Dermatology. 107(2). 164–170. 16 indexed citations
9.
Hasinoff, Brian B., Theodore I. Kuschak, Jack C. Yalowich, & Andrew M. Creighton. (1995). A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane). Biochemical Pharmacology. 50(7). 953–958. 96 indexed citations
10.
Downes, C. Stephen, Duncan J. Clarke, Ann M. Mullinger, et al.. (1994). A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature. 372(6505). 467–470. 267 indexed citations
11.
Yeung, T.K., et al.. (1992). The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat. Cancer Chemotherapy and Pharmacology. 30(1). 58–64. 23 indexed citations
12.
Nolan, Kevin B., et al.. (1990). Chelating agents as antitumour drugs: Formation of chelating agents from the antitumour pro-drug, razoxane. Inorganica Chimica Acta. 168(2). 283–288. 11 indexed citations
13.
Huang, Zhong‐Xian, Andrew M. Creighton, & David R. Williams. (1985). Metal binding properties of two homologues of razoxane, a bisdioxopiperazine antitumour drug. Inorganica Chimica Acta. 107(4). L29–L32. 3 indexed citations
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M K Ritke Breakdown of academic impact, for papers by Gene K. Yee Breakdown of academic impact, for papers by Sandra A. Murphree Breakdown of academic impact, for papers by Elisabetta Corna Breakdown of academic impact, for papers by Aurelio Di Marco Breakdown of academic impact, for papers by Y.-H. Ling Breakdown of academic impact, for papers by S Kirschenbaum Breakdown of academic impact, for papers by Abdul M. Deffie Breakdown of academic impact, for papers by Jean‐Claude Jardillier Breakdown of academic impact, for papers by Sartorelli Ac
Rankless by CCL
2026